Report Categories
View AllRecent Articles
View All
Sym Rallies On Demand News 20260401 1
Is Group 1 Gpi Stock Trading Above Fair Value Price At 323.96 Down 0.93 20260407
Is Intellia Therapeutics Ntla Stock Testing Resistance Price At 13.56 Up 3.29 20260406
Is Pepsico Pep Stock Declining Price At 156.68 Up 1.21 20260409
AIRelated Layoffs and Stock Performance A Complex Relationship
170YearOld Luxury Fashion Retailer Quietly Shuts 21 Stores Amid Sector Challenges
Geopolitical Tensions Rise as Trump Warns Iran Clock Is Ticking Market Implications
Trump Tariff Policy Remains Central Despite Legal Setbacks Advisors Signal
US Military Strikes Iranian Drone Sites After Trump Signals Negotiation Stalemate
CBSE Exam Portal Glitches and Hack Claims Prompt Government Investigation
GameSquare Holdings Receives Amended Schedule 13D Filing
AI Washing The Corporate Trend of Rebranding Ordinary Tech as Artificial Intelligence
Dow Scales Record High as SP 500 and Nasdaq Slip Amid Mixed Wall Street Session
General Compute Launches First ASICNative Neocloud for Agent Applications
Sony Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Declines
SLS Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Rises 57
CPHC Q2 2025 Earnings Narrow Loss and Modest Stock Gain Amid Quiet Quarter
URBN Q1 2026 Earnings EPS Surpasses Estimates by 114 Shares Gain 33
MGRD Q1 2026 Earnings EPS Beat Surprises Revenue Data Absent
SWBI Q1 2026 Earnings EPS Beats Estimates Despite Challenging Market Conditions
Veru Inc Holds Steady Near Support Amid Low Volatility
SMJ International Holdings SMJF Rallies 234 as Stock Approaches Resistance at 505
Invesco Trust for Investment Grade Municipals VGM Holds Steady Near 1021 Amid Quiet Trading
Five9 FIVN Surges 421 as Cloud Contact Center Stock Rebounds from Key Support
Cardlytics CDLX Edges Higher Testing Key Resistance After 4 Gain
Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution
FHTX Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances
HSAI Q4 2025 Earnings EPS Misses Estimates Stock Declines
MBX Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Clinical Development Progress
Snap Inc SNAP Q1 2026 Earnings Modest EPS Beat Amid Unreported Revenue Figures